Toilet trips were an early sign of prostate cancer, man says

A 62-year-old man in Portsmouth says repeated nighttime toilet trips led to a PSA test and a March 2020 diagnosis of stage-four prostate cancer; he is now undergoing further chemotherapy and fundraising privately for Lutetium-177 treatment.

A 62-year-old father from Portsmouth reports that needing to get up once or twice at night to urinate prompted a GP visit and testing that led to a diagnosis of stage-four prostate cancer in March 2020. His PSA blood level was substantially raised and a biopsy showed metastatic disease that had spread to lymph nodes, lungs and bones. Since then he has had rounds of chemotherapy and radiotherapy and has begun a third course of chemotherapy, with further sessions planned. He has launched a private fundraising appeal to pay for Lutetium-177 targeted radionuclide therapy as an option beyond NHS care. Key facts: - In early 2020 he consulted a GP after noticing new nighttime toilet trips. - A PSA test was markedly raised and a biopsy in March 2020 returned a diagnosis of stage-four metastatic prostate cancer. - He has received chemotherapy and radiotherapy over several years and has started a third course of chemotherapy, with further sessions scheduled. - He set up a GoFundMe to raise money for Lutetium-177 targeted radionuclide therapy and raised £32,000 within the first three days. Summary: The account describes how a subtle change in urination led to a late diagnosis and years of treatment. He is seeking private treatment funded by a public appeal while continuing chemotherapy; the outcome of the fundraising and access to the private therapy are undetermined at this time.